Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy

被引：15
作者：
Bot, P
Semmekrot, BA
van der Stappen, J
机构：
[1] Canisus Wilhelmina Hosp, Dept Paediat, NL-6500 GS Nijmegen, Netherlands
[2] Canisus Wilhelmina Hosp, Dept Clin Chem Anal, NL-6500 GS Nijmegen, Netherlands
来源：
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION | 2006年 / 91卷 / 02期
关键词：
D O I：
10.1136/adc.2004.066431
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：F153 / F153
页数：1
相关论文
共 6 条
  • [1] Isbister GK, 2001, ARCH DIS CHILD-FETAL, V85, pF147
  • [2] NIJHUIS U, 2001, FETAL NEONATAL ED, V84, pF77
  • [3] Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors
    Nordeng, H
    Lindemann, R
    Perminov, KV
    Reikvam, Å
    [J]. ACTA PAEDIATRICA, 2001, 90 (03) : 288 - 291
  • [4] Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis
    Sanz, EJ
    De-las-Cuevas, C
    Kiuru, A
    Bate, A
    Edwards, R
    [J]. LANCET, 2005, 365 (9458) : 482 - 487
  • [5] Neonatal paroxetine withdrawal syndrome
    Stiskal, JA
    Kulin, N
    Koren, G
    Ho, T
    Ito, S
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2001, 84 (02): : F134 - F135
  • [6] Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior
    Zeskind, PS
    Stephens, LE
    [J]. PEDIATRICS, 2004, 113 (02) : 368 - 375
1